Can patients’ genetic data help keep them healthy? Providers invest big to find out

281613HonorHealth is a community hospital group, not an academic medical center, but it has nevertheless committed significant resources to its research programs.

Some of its early work over the past several years has centered on finding targeted therapeutics for cancer, and it has had good success. But the five-hospital system is increasingly interested in finding biomarkers that can help predict who might be at risk for illness.

HonorHealth is one of a number of health systems that are investing in genomics and personalized medicine as the next frontier in healthcare. As providers are tasked with keeping people healthy through risk-based payment contracts, they’re searching for new ways to target patients who need early intervention. Venture capital funds also have been flowing into the space, as investors expect rapid growth.


About Peter Coffaro 1134 Articles

A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.